In the realm of cancer research, the formulation of anticancer drugs represents a cornerstone in the fight against this formidable disease. Scientists continually innovate to develop drug formulations that target cancer cells while minimizing damage to healthy tissues. Nanotechnology has emerged as a promising avenue, enabling the precise delivery of therapeutic agents directly to tumors, thereby enhancing efficacy and reducing side effects. Furthermore, advancements in personalized medicine have led to tailored drug formulations based on an individual's genetic makeup and the specific characteristics of their cancer. By harnessing cutting-edge technologies and interdisciplinary approaches, researchers strive to develop increasingly sophisticated anticancer drug formulations that offer improved outcomes and better quality of life for patients battling cancer.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States